Patents Assigned to Newcastle Innovation Limited, of Industry Development Centre
  • DETECTION OF A BIOMARKER OF ABERRANT CELLS OF NEUROECTODERMAL ORIGIN IN A BODY FLUID
    Publication number: 20100021929
    Abstract: Assays and kits for detecting aberrant cells of neuroectodermal origin in a body fluid of an individual, comprising testing for expression of GLAST1b as a biomarker of the cells are disclosed. Intact GLAST1b and/or fragments thereof may be detected in the fluid. Alternatively, another analyte indicative of the expression of GLAST1b by the cells may be detected. The assay is particularly suitable for detecting expression of aberrant neuronal populations such as resulting from brain hypoxia. The fluid can be cerebrospinal fluid (CSF).
    Type: Application
    Filed: March 20, 2009
    Publication date: January 28, 2010
    Applicant: Newcastle Innovation Limited, of Industry Development Centre
    Inventor: David V. Pow